Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Contravisory Investment Management Inc.

Contravisory Investment Management Inc. reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,092 shares of the medical equipment provider’s stock after selling 82 shares during the period. Contravisory Investment Management Inc.’s holdings in Intuitive Surgical were worth $570,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical during the 3rd quarter worth approximately $558,807,000. International Assets Investment Management LLC boosted its holdings in shares of Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC increased its stake in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB raised its holdings in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, State Street Corp lifted its position in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 in the last three months. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $580.11 on Thursday. The stock has a market capitalization of $206.62 billion, a PE ratio of 93.27, a P/E/G ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $584.60. The company’s 50-day simple moving average is $537.05 and its 200-day simple moving average is $496.50.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on ISRG. Leerink Partners lifted their price target on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Finally, Raymond James increased their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.